(Q46464670)

English

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study

scientific article published on 13 October 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study (English)

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

Pamela T Soliman

1

object named as

Pamela T Soliman

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

6

object named as

Mark F Munsell

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Melinda S. Yates

8

object named as

Melinda Yates

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Shannon N. Westin

4

object named as

Shannon N Westin

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

10

object named as

Karen H Lu

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

author name string

Qian Zhang

2

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Russell R Broaddus

3

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

David Iglesias

5

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Rosemarie Schmandt

7

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Lois Ramondetta

9

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

language of work or name

0 references

publication date

13 October 2016

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Gynecologic Oncology

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

143

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

3

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

466-471

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Metformin intake is associated with better survival in ovarian cancer: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Prospective evaluation of insulin resistance among endometrial cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Antidiabetic therapies affect risk of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Diabetes and risk of endometrial cancer: a population-based prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Metformin and reduced risk of cancer in diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

24 May 2018

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

15 August 2018

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

15 August 2018

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5116402

15 August 2018

Identifiers

10.1016/J.YGYNO.2016.10.011

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 December 2017

http://europepmc.org/abstract/PMC/5116402

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46464670&oldid=2127142303"